Semler Scientific (NASDAQ:SMLR - Get Free Report) is anticipated to post its quarterly earnings results before the market opens on Tuesday, March 4th. Analysts expect the company to announce earnings of $0.20 per share and revenue of $12.00 million for the quarter. Parties interested in registering for the company's conference call can do so using this link.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last posted its quarterly earnings results on Tuesday, February 18th. The company reported $3.41 EPS for the quarter, topping the consensus estimate of $0.20 by $3.21. The company had revenue of $12.41 million for the quarter. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%.
Semler Scientific Stock Performance
Semler Scientific stock traded up $2.29 during trading hours on Friday, hitting $42.92. The company had a trading volume of 420,679 shares, compared to its average volume of 360,829. The firm has a market cap of $397.74 million, a P/E ratio of 8.74 and a beta of 1.17. The company has a 50-day moving average price of $54.34 and a two-hundred day moving average price of $43.14. Semler Scientific has a 1 year low of $20.88 and a 1 year high of $81.56.
Analyst Upgrades and Downgrades
Separately, Lake Street Capital increased their price objective on Semler Scientific from $40.00 to $71.00 and gave the stock a "buy" rating in a research note on Friday, January 24th.
View Our Latest Analysis on SMLR
Semler Scientific Company Profile
(
Get Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Featured Articles

Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.